| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25467b8fc2d934f7dfbbb3c576f1459e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bee46000e3698d2fb25999b0c193ba5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e451b8e11993ed58d0f7c17cbbc2060
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f44341739f0d538b7d197d096ee428d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d6b430053bbabf258f0b4a32e0e2845 |
| publicationDate |
2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020014399-A2 |
| titleOfInvention |
FACTOR H ENHANCING ANTIBODIES AND THEIR USES |
| abstract |
The present invention relates to new isolated, synthetic or recombinant antibodies and their specific fragments for factor H. The present invention also relates to the use of such antibodies and fragments to inhibit complement activation and to treat disorders associated with complement activation. . |
| priorityDate |
2018-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |